The type-II TGFB receptor mediates many of the biological responses to TGFB. An examination of the expression of the type-11 TGFB receptor during mouse embryogenesis therefore provides specific information about the role of TGF/3 during embryogenesis than has been available to date. We have isolated the genomic murine homologue of the human type-II TGFj3 receptor corresponding to exon 2. The murine and human sequences show a high degree of homology. Using the murine probe, we found that type-II TGFfi receptor expression is regulated in both a spatial and a temporal fashion by using in situ hybridization and ribonuclease protection assays. Type-II TGF#l receptor expression is localized to the mesenchyme during critical interactions with adjacent epithelium such as developing hair follicles, whisker follicles and tooth anlage. In the central nervous system, type-II TGFB receptor expression is highly restricted to the floor plate. Strong expression is also detected in migrating neural crest cells, meninges, and choroid plexus. Specific mesenchyma1 localization of type-II TGFB receptor is also observed in lung, kidney, intestine, stomach, and bladder. The restricted expression of type-II TGF@ receptor in mesenchymal cells at sites of epithelial-mesenchymal interactions suggests that type-II TGF/? receptor plays a major role in mediating the establishment of embryonic organ systems. The highly restricted expression of type-II TGFB receptor in the developing CNS suggests an important role for a serine/threonine kinase in patterning of the nervous system.
Introduction
Vertebrate embryogenesis involves a complex set of interactions between different tissues and cell types (Gurdon, 1992) . Polypeptide growth factors have been found to play an important role in many morphogenetic events during vertebrate development (Whitman and Melton, 1989; Jesse11 and Melton, 1992) . The transforming growth factor /3 (TGFB) family comprises about 20 members, including TGFBI-5, activin, inhibin, MIS, dpp, BMP, vgr-1, vg-1. (MassaguC, 1990; Roberts and Sporn, 1990) . Multifunctional properties of TGFj3 have been described in tissue culture studies, which include inhibition or stimulation of cell proliferation, increased extracellular matrix production and regulation of cellular differentiation. TGFBs have also been implicated in mediating cellular interactions, epithelial-mesenchymal interactions and mesoderm induction during embryonic development (Whitman and Melton, 1989; MassaguC, 1990; Nilsen-Hamilton, 1990; Pelton et. al., 1991; Jesse11 and Melton, 1992) . The signal generated by TGFP is transduced to cells via a set of cell surface proteins that have been identified through their ability to bind and be chemically crosslinked to radioiodinated TGF/? (Massague and Like, 1985) . There are three types of TGFP receptors. TGFj3RI (type-I TGFj? receptor) and TGFBRII (type-11 TGF/? receptor) have a high affinity for TGF/3 with a M, 0925-4773/95/! §09.50 0 1995 Elsevier Science Ireland Ltd. All rights reserved SSDI 0925-4773(95)00408-S of 53 X lo3 and 70 X 103, respectively. TGFBRIII (type-III TGFB receptor, also known as betaglycan) binds TGF/3 with lower affinity and has a relative M, of 100 X 10' (Cheifetz et al., 1988; Cheifetz and Massague, 1989) The TGFPRII had been isolated by using an expression cloning strategy (Lin et al., 1992) . It contains a cysteine-rich ectodomain, a single transmembrane domain, and a cytoplasmic domain with serine/threonine kinase activity (Lin et al., 1992) . In comparison to other mitogen receptors with a tyrosine kinase domain, TGFBRII belongs to a novel class of receptor serine kinases, which includes Daf-1, ActRIIB, ActRII, TGFPRI, due to their high level of homology in the cytoplasmic serine/threonine kinase domain. The ectodomain structural motifs of TGFPRI and II are highly conserved in their localization of cysteine residues, suggesting a potential role in the determination of TGFD binding specificity (Ebner et al., 1993) . However, the ectodomain of TGFJ?RI and II have only limited homology with the activin-receptor (Lin et al., 1992; Ebner et al., 1993) . In contrast, the TGFBRIII has no significant homology to TGFPRI and II. TGFPRIII has only a short intracellular domain with no obvious signaling motif (Lopes-Casillas et al., 1991; Wang et al., 1991) . It is hypothesized that the TGFBRIII functions as a receptor accessory (Massague, 1992) . Several lines of evidence support the notion that TGFBRII lie at a key position in the TGFP signaling pathway. First, mutagenized mink lung epithelial cells containing a defective TGFBRII are resistant to the growth inhibitory effects of TGFB (normally characteristic of these cells) in spite of having normal TGF/?RI expression (Boyd and Massague, 1989; Laiho et al., 1990; Laiho et al., 1991) Second, expression of a dominant negative mutant of the TGF/?RII inhibits TGFP induced growth inhibition of epithelial cells (Wrana et al., 1992; Chen et al., 1993; Inagaki et al., 1993) and inhibits the activation of mesoderm specific genes in vitro (Brand et al., 1993) . It is further postulated that the inhibitory effect of the TGF@ is via heterodimerization of the TGF/?RI and TGFBRII (Wrana et al., 1992; Ebner et al., 1993; Inagaki et al., 1993) . A large number of laboratories have reported the expression patterns of the TGF@ family members during murine development (Heine et al., 1987; Akhurst et al., 1990; Pelton et al., 1990 Pelton et al., , 1991 Millan et al., 1991; Schmid et al., 1991; Dickson et al., 1993) , however, in the absence of studies showing the expression of the appropriate TGF@ receptor, the conclusions of these studies remain incomplete. Given that the TGFBRII is essential for TGFP signaling, a study of the TGFPRII expression in the mouse embryo should provide significant insights into the role of TGFP during embryogenesis. Thus, in this report, we have cloned the murine genomic exon 2 for TGFBRII and found a high degree of conservation between the murine and human gene. We describe the expression of TGFBRII mRNA during mouse embryogenesis.
TGFBRII expression is regulated in both a spatial and a temporal fashion and is restricted to mesenchymal cells at sites where epithelial-mesenchymal interaction occur, suggesting that TGFBRII plays a major role in mediating embryonic organ modeling and morphogenesis.
A previous study using in situ hybridization during early mouse embryogenesis revealed that the TGFBRII was not present in the nervous system (Roelen et al., 1994) . In contrast, we see very discreet and striking patterns of expression in the floor plate and in the hindbrain, suggesting an important role for serinei threonine kinases in nervous system patterning and in compartmentalization of the CNS.
Results

I. Cloning of mouse exon 2 of the TGF,L?RII
In order to more accurately demonstrate the distribution of TGF@RII in the mouse embryo, the mouse TGFBRII sequence was isolated for further studies. A small segment of the 5' region of the human TGFBRII DNA was used to probe a mouse genomic library and the putative exon 2 of the TGFBRII was isolated within a 15 kilobase mouse genomic fragment (Fig. 1Ci) . The sequence of this exon was compared to that of the available human TGFBRII clone and found to be 92% identical at the amino acid level (Fig. 1B ) but only to share 83% identity at the DNA level (Fig. 1A) . This fragment was used to target the single DNA sequence encoding exon 2 of the mouse TGFBRII in embryonic stem cells, suggesting that it represents the true coding region of exon 2 of the mouse TGF,!?RII (data not shown). The 500 base pair HincII/EcoRI fragment containing exon 2 of the mouse TGFBRII was then used to generate the probes for the subsequent expression analyses. A control sense probe was generated by digesting the vector with PstI to generate a 120 bp probe containing the 5' region of exon 2. A specific antisense probe was generated using the entire exon 2 sequence by digesting with HincII (Fig. lCii, Fig.  1A ).
TGFfiRH mRNA expression increases during organogenesis
In our initial investigation of TGF@RII expression during mouse development, we examined the expression of TGF#?RII mRNA at different stages of mouse embryogenesis using ribonuclease protection assays. As shown in Fig. 2 , low levels of TGFPRII mRNA are detected at the onset of organogenesis (9 days post-coitum or dpc to 12 dpc). TGFBRII mRNA levels increase during late fetal stages (13-17 dpc). Therefore, TGFPRII transcription is regulated in a temporal fashion during mouse embryogenesis. The sudden increase of TGFPRII in fetal stage (13 dpc+) suggests a major role for TGFj3RII in organ morphogenesis.
TGFflRII mRNA expression in adult mouse tissues is
As shown in Fig. 2 A major protected fragment is detected at all stages examined (see arrow) As can be seen, TGF/IRII mRNA increases as development proceeds. (Right) TGFBRII expression in adult tissues. High levels of TGFBRII mRNA can be found in heart (h), uterus (ut), fat, lung, kidney (kdy). Low, but clear detectable signals can be seen in the skeletal muscle (skm), liver (Ivr), brain, intestine (int) and stomach (stm). Thus, TGFBRII has a ubiquitous expression pattern in adult tissues. Each reaction contains 2Opg total RNA. The quantity and quality of each RNA samples are verified (data not shown). Yeast RNA (YR) was used in both assays as a negative control which yields no detectable signal.
TGFPRII has ubiquitous expression in all tissues we have examined, suggesting that TGFPRII may play a fundamental role in adult tissues.
TGF,8RII expression initiates during early organogenesis
To address the role of TGFBRII during development and to determine the site of TGF/? action, in situ hybridization analyses of TGFj?RII mRNA was carried out on sectioned mouse embryos from early gastrulation (6.5 dpc) to late organogenesis (16.5 dpc). To control for non-specific hybridization, a 35S-labeled sense strand of TGFPRII was used, and no hybridization signal was observed in several different stages of embryo sections (data not shown). Using the antisense probe, TGF/3RII mRNA is not detected in the embryo proper at the onset of gastrulation. However, strong signal can be observed in the uterine decidua and the allantoic trophoderm. The expression in the extraembryonic membrane persists through 8 dpc and no expression in embryo proper is observed at this stage (data not shown). The first detectable TGFPRII expression in the embryo proper is seen at 9 dpc at moderate levels in migrating neural crest cells, cephalic mesenchyme, maxillary processes, and endothelial cells of the cardiac tube. TGFBRII signal is not observed in the entire central nervous system at this stage ( Fig. 7A ).
TGFBRII expression in the developing skeletal system
The vertebrae originate from the sclerotome which arise from somitic mesoderm. The intervertebral discs and vertebrae are derived from condensation of the posterior and anterior portions of each sclerotome (Rugh, 1990) . The condensations form in a rostral-caudal direction. TGFPRII expression is first observed in the sclerotome portion of the somites at low levels (data not shown). Later, TGFPRII expression becomes restricted to the intervertebral discs (Figs. 3C and 4A) . No expression can be detected in the condensing cartilage, and chondrocytes in the rostra1 portion of the vertebral column (Figs. 4A and 3C). The progenitors of the appendicular bones are initially derived from the lateral plate mesoderm. Limb bone formation involves a condensation of limb bud mesenchyme which forms a cartilage skeleton which is replaced by osteogenic cells (Rugh, 1990; Kaufman, 1992) . TGFBRII expression first can be observed in the early limb bud at low level in a diffused pattern (data not shown). As limb mesenchyme condensation occurs, expression becomes restricted to the dorsal and ventral limb mesenchyme only (Fig. 3A,B) . Later in development, TGFPRII expression is detected in the loose mesenchyme surrounding the periosteum and proliferative cells of the epiphyseal plate (Fig. 4B ). In contrast, most craniofacial bones are formed directly from the interaction of neural crest craniofacial mesenchyme with the extracellular matrix of epithelial cells by a process known as intramembranous ossification (Rugh, 1990; Kaufman, 1992) . The TGFj%UI transcripts can first be seen in the neural crest cells and cephalic mesenchyme (Figs. 3A,B and 7), maxillary processes (Figs. 3B,C and 7A) and palate shelf (Figs. 4C and 3D) . TGFPRII expression is detected in the mesenchyme underlying the forming membranous bone (Figs. 4C and 3D) . TGFjlRII signal can also be seen in the inner lining of the nasopharynx cavity (Fig. 4C) . The first indication of tooth formation starts around day 12 (Rugh, 1990) . Tooth development involves a series of epithelialmesenchymal interactions, during which oral epithelium induces neural crest derived mesenchymal cells to aggregate and become the dental papilla. The superficial layers of mesenchyme are induced to form the dentine-secreting odontoblasts whereas the rest of the central mesenchyme becomes the dental pulp. The mesenchyme induces the dental lamina to proliferate and differentiate into enamelsecreting ameloblasts (Lumsden, 1988; Thesleff et al., 1989) . TGF/?RII expression can be observed in the condensing mesenchyme underlying the oral epithelium and the invaginating dental lamina shows no detectable signal for TGF/?RII at 13.5 dpc (Fig. 4D) . By 15.5 dpc, the maturing teeth show distinct ameloblast and odontoblast layers. TGFPRII signal can be observed only in the odontoblast layer and the dental papilla (Fig. 4E) . However, TGFBRII signal is not detected in the ameloblast layer at this stage (Fig. 4E ).
TGFflRlI expression in the embryonic internal organs
The heart is derived from lateral plate mesoderm. Cardiogenic cells form a double-walled cardiac tube consisting of an inner endocardium which ultimately forms the endothelium of the heart. The epimyocardium forms the cardiac muscle proper. At 9 dpc, the endocardium and epimyocardium fuse to form a single cardiac tube (Rugh, 1990; Kaufman, 1992) . Strong hybridization for TGF/?RII is detected in the endocardium (Figs. 5A and 7A), but is not detected in the myocardium. Formation of the endocardial cushions and outflow tract of the heart involves a Fig. 5 . TGFpRll expression in embryonic internal organs. (A) Parasagittal section of a 10.5 dpc heart. Strong signal can be detected in the endothelial cells and endocardial cushion (ec) of the heart. (B) Parasagittal section of a 14.5 dpc heart. Endothelial cells continue to express TGF/3RII and strong signal is also seen in the outflow tract (*) of the heart. (C) Parasagittal section of a 15.5 dpc kidney and pancreas (p). TGF/?RII expression is restricted to the mesenchymal cells of the kidney, whereas no expression is seen in the collecting tubules. TGF/IRII signal is not detected in the developing pancreas. (D) Parasagittal section of a 15.5 dpc lung. Strong signal is detected in lung mesenchyme. No signal is seen in the major bronchiolar epithelial cells (long arrow). However, signal is clearly detectable in the epithelial lining of the alveoli sac.(arrow) (E) Frontal section of a 14.5 dpc embryo. Strong expression is seen in the basement membrane as well as the mesenchyme surrounding the epithelial lining of the stomach (s) and duodenum (d) . No expression can be found in the epithelial lining nor in the smooth muscle layer of the gut. TGFBRII signal cannot be detected in the liver (Iv) between mouse gestation 9 and 16.5 dpc. However, low levels of TGFBRII are detected in the adult tissue ( series of epithelial-mesenchymal transformations during which the endothelial cells respond to a signal from the myocardium and form a morphologically distinct mesenthyme (Krug et al., 1985; Mjaatvedt et al., 1987) . During this process, TGFBRII mRNA can be found in the endocardial cushions (Fig. 5A ) and outflow tract (Fig.  5B) where endothelial-mesenchyme interactions occur. TGFBRII expression continues in endothelial cells of the heart in later embryonic stages (Figs. 3C,D and 5B). Kidney development arises from a reciprocal epithelialmesenchymal induction of the ureteric bud and metanephrogenic mesenchyme.
TGFBRII is found first in the metanephric mesenchyme (data not shown). Later, expression is detected in the surrounding stromal mesenthyme (Figs. 3C and 5C ). During the formation of the kidneys at day 15.5 pc, no signal was observed in the metanephric tubule which is derived from the metanephric mesenchyme (Fig. 5C ). The medulla of the adrenal gland is derived from neural crest cells, whereas the cortex of the adrenal gland is derived from splanchnic mesoderm. High levels of expression can be found in both the medulla and the cortex portion of the adrenal gland (data not shown). TGFfiRII expression is also observed in the mesenchyme surrounding the bladder epithelium (Fig. 5G) . The embryonic primitive gut contributes to both the digestive and respiratory tracts. TGFBRII is expressed in the pharyngeal pouch (Fig. 3A) and in the pharyngeal pouch derived thymus (Fig. 5H) , which produce T-lymphocyte during later development. Strong signal can also be detected in the submandibular gland ( Fig. 3D ) and thyroid gland (data not shown) which are derived from the epithelial outpocket of the pharynx (Kaufman, 1992) . Foregut epithelial cells also contribute to the inner lining of the stomach and intestine whereas the stroma is derived from mesoderm. TGFBRII mRNA is found to be restricted to the stroma and is not detected in the inner epithelial lining and smooth muscle layer of the gut (Figs. 5E and 3D ). In the large intestine, TGFBRII expression is found adjacent to the tip of the villi (Fig.  5F ). The primitive gut also gives rise to the spleen, pancreas, and liver, where TGFBRII expression is not detected (Figs. 3 and 5C ,E). However, low levels of TGFPRII expression is detected in the adult liver (Fig. 2) . Lung bud formation is the result of a ventral extension of the laryngotracheal groove between the fourth pharyngeal arch followed by the bifurcation to form paired bronchi. Lung mesenchyme induces the epithelium of the bronchi to branch into terminal airways (Joyce-Brady and Brody, 1990; Kaufman, 1992) . At 9.5 dpc, when the lung bud first appears, TGFPRII is found in the mesenchymal cells surrounding the lung bud epithelium however no expression is seen in the lung bud epithelial cells (data not shown). By 13 dpc, the lungs have expanded dramatically, with the progressive branching and formation of numerous bronchi (Kaufman, 1992) . TGFPRII expression is restricted to the still homogeneous parenchyma of the lung, and no expression can be found in the inner epithelial lining of the bronchi (Fig. 3C) . By 15.5 dpc, the basic architecture of the lung is established (Kaufman, 1992) . Strong TGFBRII signal is found in the parenchyma, with a weaker but clearly detectable signal in the terminal epithelial component of the alveoli (Figs, 5D and 3D ).
TGFBRII expression in the developing sensory organs and intergumentary system
Eye development involves a series of inductive interactions. The lens vesicles arises as an invagination of the surface ectoderm. By 11 dpc, a distinct sensory and pigment layer of the retina can be observed (Rugh, 1990; Kaufman, 1992) . Later, the developing lens induces the formation and differentiation of the cornea. TGFBRII expression is found in the cornea, eyelid, and head mesenchyme surrounding the pigment layer of retina (Fig.  6A) . TGFBRII mRNA cannot be detected in the neural and pigment layers of the retina, nor in the lens fiber and lens epithelium (Fig. 6A) . The formation of the olfactory placode marks the developmental onset of the olfactory apparatus. The inner lining of the nasal chambers are covered with olfactory epithelium, which show no detectable signal for TGF/?RII (Figs. 6B and 3C,D) . The mesenthyme adjacent to the -olfactory epithelium shows strong hybridization for TGFPRII (Figs. 6B and 3C,D) . Inner ear formation initiates with a thickening and invagination of the auditory placode to form the auditory vesicle. This process is driven by sequential interactions between the epithelium of the otocyst and mesenchyme of the periotic tissue (Rugh, 1990) . TGFBRII expression can be seen in the mesenchyme surrounding the inner ear, but not the epithelial of the cochlea (Figs. 3A and 6C ). TGFPRII signal is also found in mesenchymal cells adjacent to the condensing cartilage of the pinna (Fig. 6D) . The early skin consists of a single layer (the periderm). By 14 dpc, skin differentiation initiates. Stratum germanativum arises at 15 dpc (Rugh, 1990; Kaufman, 1992) . TGFPRII expression can be observed in the mesenchyme underlying the periderm, but not the periderm itself (Figs. 3C and  4A ). Later, TGF#?RII is found in the dermis whereas the epidermis shows no detectable signal for TGFBRII (Figs.  3D and 6E,F) . The reciprocal interactions of the epidermis and underlying dermis contribute to the hair and whisker follicle formation (Davidson and Hardy, 1952) . TGFPRII is detected in the papilla dermal sheath primordium and mesenchyme surrounding the hair and vibrissae (Fig. 6E,F ) but no expression is observed in the hair follicles.
TGFPRII expression in the embryonic nervous system
Development of the nervous system involves the induction of neural plate formation, neural tube closure, and formation of the prosencephalon, mesencephalon, and rhombencephalon along the anterior-posterior axis. Subsequently, the rhombencephalon divides into the anterior Fig. 6 . TGFPRII expression in the developing sensory organs and intergumentary system. (A) Parasagittal section of a 13.5 dpc embryo. Strong expression is detected in the mesenchymal cells surrounding the eye. TGF#IRII signal is observed only in the cornea (c) at low levels whereas no expression can be detected in the lens fiber (I), lens epithelium, and retina. Note that the pigment epithelium appears labeled using darktield optics; however this is due to refraction. (B) Parasagittal section of a 15.5 dpc nasal chamber (n). TGFBRII expression is restricted to the mesenchymat cells (arrow) surrounding the olfactory epithelium (0) 
d). TGFBRII expression is not detected in the whisker follicle (w). (F).
Parasagittal section of a 15.5 dpc hair follicle. Strong signal is seen in dermal papilla (dp) as well as in mesenchyme (arrow) adjacent to the out root sheath of hair follicle. TGFpRIl expression is also found in the dermis (d), but not in the epithemis (e) and hair follicle (h). (A-E) Bar = 50pm; (F) bar = IOpm. metencephalon and the posterior myelencephalon. At the cellular level, the ventral midline cells of the hindbrain and spinal cord comprise the floor plate, which is induced by the underlying notochord (Jesse11 and Dodd, 1992). TGFj3RII expression is restricted to the ventral midline cells of the hindbrain (Fig. 7B,D) . The derivatives of metencephalon , such as the pons, show restricted expression of TGFPRII to the mantle zone (Fig. 7C,D) . However, TGFPRII expression cannot be detected in the cerebellum (also derived from the metencephalon, Fig. 7C ). Strong expression of TGFBRII is also detected in the ventral portion of medulla oblongata (Fig. 7D) , which is derived from the myelencephalon.
TGFBRII expression is found throughout the ventral floor of the spinal cord (Fig. 7E , data not shown). The anterior limit of its expression is at the mid-hindbrain junction (Fig. 7D) . The choroid plexus, which serves to produce cerebrospinal fluid, and cephalic mesenchyme, expresses high levels of TGFPRII mRNA (Fig. 7C,D) . TGF/?RII expression is also found in the meninges (Fig. 7C,D) , which arise from a condensation of cephalic mesenchyme. TGF/?RII is found in the migrating neural crest cells (Fig. 7A,E) . No expression of TGFPRII can be observed in the dorsal root ganglia (Fig. 7E) . A recent report examining TGFPRII expression during embryogenesis concluded that no expression could be detected in the CNS (Roelen et al., 1994) . The reasons for this discrepancy are unclear since we detect very clear and strong expression in discreet domains of the CNS.
Discussion
TGFPRII in epithelial-mesenchymal
interactions The TGFP family of growth factors has been implicated in the control of cell proliferation, differentiation, ECM production, and morphogenesis. TGF@ family member expression patterns during mouse embryogenesis have been studied extensively over the last several years. One prominent site of expression for these factors is at sites of epithelial-mesenchymal interactions (Heine et al., 1987; Akhurst et al., 1990; Pelton et al., 1991; Dickson et al., 1993) . Formation of the endocardial cushions, which give rise to the valve and septum of the heart, involves a series of epithelial-mesenchymal transformations and regional cellular differentiation.
Endothelial cells receive a signal from the underlying myocardium of the AV canal and outflow tract to initiate the formation of mesenchyme (Krug et al., 1985; Mjaatvedt et al., 1987) . TGF/?l or /?2 in combination with the myocardium, can mediate the epithelial-mesenchymal transformation in an in vitro collagen gel bioassay and this effect can be blocked by the antibodies against TGFPl and p2 (Potts and Runyan, 1989) . TGFP3 is essential for this process as observed by using an antisense oligo in this bioassay (Potts et al., 1991) . These results suggest that TGF/3-like molecules are probably present in the myocardium and mediate the epithelium-mesenchyme transformation. In support of this theory, TGFp2 mRNA and protein are found to be localized at the endocardial cushion and outflow tract of the embryonic heart suggesting that TGFP2 may act as an inducer originating from the myocardium base (Akhurst et al., 1990; Dickson et al., 1993; and see Heine 1987) . In this study, we substantiate this hypothesis by demonstrating that the mRNA encoding the major TGFP signaling receptor, TGFBRII, is first detected in the endocardium of the cardiac tube and restricted to the endothelial cells. The highest expression is seen in the endocardial cushion and outflow tract where extensive epithelial-mesenchyme interactions occur. No expression can be detected in the myocardium and septum. While previous studies of the localization of the ligand mRNAs and proteins suggested that TGFP acts in a paracrine fashion during embryogenesis (Akhurst et al., 1990; Dickson et al., 1993; and see Heine 1987) , studies of the TGFBRII mRNA embryonic expression strengthen this theory. Our observations of the temporal and spatial expression of the TGFBRII mRNA in the developing mouse heart strongly suggest that TGFP acts via a paracrine regulatory mechanism during this process of epithelial-mesenchymal transformation. Development of the teeth and hair follicle also involves a sequence of reciprocal interactions between the epithelium and mesenchyme (Davidson and Hardy, 1952; Lumsdem, 1988; Thesleff et al., 1989) . Previous studies have shown that TGFP family members are involved in this process (Pelton et al., 1990 (Pelton et al., , 1991 and see Heine, 1987) . Here, we show that TGFBRII expression is mesenthyme-specific and is restricted to mesenchymal derivatives such as dermis, pulp, and odontoblast. No expression can be seen in epithelial derivatives, such as dental lamina, ameloblast, as well as hair follicles and epidermis. TGFBRII expression is coordinate in a temporal and spa Fig. 7 . TGF/?RII expression in developing nervous system. (A) Frontal section of a 9.5 dpc embryo. TGFfiRIl signal is seen in the migrating neural crest cells (nc). TGFBRII expression can also be found in the maxillary processes (mx), mandibular processes (m) and heart (h). No signal can be detected in the entire central nervous system including the diencephalon (d). (B) Frontal section of a 12.5 dpc embryo. TGFBRII expression is restricted to the floor plate (f) of the hindbrain and cephalic mesenchyme. No signal can be detected in the pituitary gland (pg). (C) Parasagittal section of a 13.5 dpc embryo. TGFBRII expression is seen in the pons (p), cephalic mesenchyme (cm), choroid plexus (cp) and meninges. No signal can be detected in the cerebellum primordium (cb). (D) Sagittal section of a 14.5 dpc embryo. Strong TGFBRII signal is restricted to the pons (p) and medulla oblongata (mo). No expression is seen in the midbrain (mb) and roof plate (r). TGFBRII expression is also detected in the choroid plexus (cp), meninges (mg) and cephalic mesenchyme (cm). (E) Frontal section of a 12.5 dpc embryo. TGFBRII signal is found in the neural crest cells (nc) and is restricted to the floor plate (0 of the spinal cord (SC). No signal is seen in the ganglia (g), spinal cord (SC) and notochord (nc). (A,C,D) Bar = 50pm; (B,E) bar = 50pm.
tial manner with the expression of members of the TGF/I superfamily (Pelton et al., 1991; see Heine, 1987) . For example, TGFB protein is detected in the dental pulp and odontoblast layer but not the dental lamina and ameloblast layer (Heine et al., 1987; Pelton et al., 1991) . In contrast, the formation of the inner ear also involves epitbelial-mesenchyme interactions. TGF/32 protein has been localized to the basement membrane of the cochlear epithelium (Pelton et al., 1991) and TGFP-like molecules may be present in the epithelium which modulate chondrogenesis in the underlying mesenchyme (Frenz et al., 1992) . In this study, we demonstrate clearly that TGFBRII expression is restricted to the mesenchyme surrounding the epithelium of the inner ear (Fig. 6C) . The specific expression of TGFBRII in mesenchyme can also be detected in the gut where TGFjIl protein is located at the tip of the villi (Pelton et al., 1991;  Fig. 5F ). Therefore, we conclude that TGFBRII may be receiving a signal (ligand) from either the epithelium or mesenchyme to regulate ECM production and mesenchyme remodeling.
TGFPRII in nervous system development
We have demonstrated that TGFBRII transcripts are strictly localized to the ventral midline cells of the hindbrain and spinal cord. These regions of the CNS comprise the floor plate which is induced by the underlying notochord along the ventral neural tube. The floor plate has been shown to play an important role in axonal guidance, and the patterning, and differentiation of the neural tube along the dorsal-ventral axis (Schoenwolf and Smith, 1990; Yamada et al., 1991; Jesse11 and Dodd, 1992; Hatta et al., 1992) . Recent experiments have shown that TGFfi2, but not TGFP 1 or /33, is expressed in the ventral mid-line cells of the mouse embryo (Dickson, et al., 1993, our unpublished observations) suggesting a possible interaction between TGF/?2 and TGFBRII which in turn may regulate the formation and differentiation of the floor plate and the establishment of posterior and ventral positional value in the central nervous system. This is similar to the proposed role for other members of the TGFB family such as the decapentaplegic (dpp) gene in regulating the dorsalventral patterning of the Drosophila embryo (Ferguson and Anderson, 1992) and activin-like molecules in establishing the positional value along the anterior-posterior axis of the frog embryo (Green et al., 1992) . The expression of TGFPRII mRNA in migrating neural crest cells and neuroblasts suggests additional roles in cell migration probably by modulating the secretion of chemotactic factor (Postlethwaite et al., 1987) or neurotrophic factor (Lindholm et al., 1992) and the production of ECM migration pathways (Nilsen-Hamilton, 1990 ). Indeed, dorsalin, a novel TGFP family member, can induce the migration of neural crest cells from the neural plate explant (Basler et al., 1993) . Recent studies show that the fork head gene family members may underlie patterning of the CNS. Sasaki and Hogan (1993) have cloned fork headlike genes in the mouse (HNF-3B, HNF3a, MF-I and MF-2). In the CNS, restricted expression of HNF3B to the floor plate corresponds to the expression domain of TGFPRII. HNF-3B is also expressed in the notochord in addition to its colocalization with TGF/?RII in the floor plate. Thus, it is possible that HNF-3B regulates the secretion of a notochord signal and induces the expression of TGFBRII in the floor plate. TGFBRII in conjunction with HNF-3B as well as other factors could modulate the floor plate differentiation and regional specification. To our knowledge, this is the first report to show that TGF/3RII is expressed in a restricted domain of the hindbrain and spinal cord and implies that serine/threonine kinase signaling pathways may play an important role in patterning the anterior-posterior and dorsal-ventral axis of the CNS.
In vivo ligands and a developmental role for TGFPRII
TGFBRII as well as TGFBRI can discriminate between various forms of TGF@ and binds TGF/?l and 83 with higher affinity than TGF/I2 (Cheifetz et al., 1990) . The description of TGF/?l-3 expression during mouse embryogenesis as revealed by in situ hybridization and immunohistochemical staining has generated some conflicting results. The existence of the TGFPlITGFB2 heterodimer, which binds to the receptor with higher affinity than the TGF/IZ homodimer (Cheifetz et al., 1987) , has made the issue more complex as to the in vivo ligand for TGFBRII. However, the previously described expression patterns of TGFPl-3 and the pattern of TGFPRII expression described in this report do show a high level of correlation. In particular, the sites of embryonic expression of the TGFB2 protein (Pelton et al., 1991; Dickson et al., 1993) , which binds TGFPRII with lower affinity than TGF/?l and 83 in vitro (Cheifetz et al., 1990) , are very similar to the sites of expression of the TGFPRII, particularly at key locations during tissue morphogenesis and differentiation.
For example, TGFPRII and TGFB2 are expressed in adjacent tissues during heart morphogenesis ( Fig. 5A,B ; Dickson et al., 1993) suggesting that TGFP2 and TGFPRII involves a paracrine mechanism regulating the epithelial-mesenchyme transformation of the endocardial cushion. TGFBRII and TGF/IZ are also expressed in the same cell types in the developing teeth. At the tooth bud stage, TGFBRII and TGF#I2 are restricted to the dental mesenchyme, but later at the cup stage, TGFBRII and TGFp2 also show restricted expression in mesenchyme derivatives, such as dental pulp, and odontoblast layer. No expression can be detected in the dental lamina nor ameloblast layer (Pelton et al., 1990 (Pelton et al., , 1991 this report) . The most striking colocalization of TGFPRII and TGFP2 occurs in the central nervous system. They are both expressed in the meninges, neural crest cells, cephalic mesenchyme, ventral midline cells of the hindbrain and spinal cord. TGFBRII has an anterior expression boundary at the mid-hindbrain junction, where TGFP2 has a slightly extended expression to the midbrain (Milan et al., 1991; Dickson et al., 1993; our unpublished observation.) . TGFPRII shows limited colocalization with TGF/?l in only the neural crest derivatives such as meninges, cephalic mesenchyme, and neural crest cells. TGF/33 is not expressed in the CNS except in the meninges and choroid plexus (Milan et al., 1991; Pelton et al., 1991; our unpublished observation.) . Therefore, we suggest that TGFp2 is the most potent ligand for the TGFPRII in vivo. Previous studies have shown that TGFPRII is involved in the growth inhibition of epithelial cells in vitro. However, we found that TGFPRII xpression in epithelial cells is only detected in very limited areas in the embryo, such as epithelial lining of the nasopharynx cavity and the lung alveoli sac. The lack of TGFPRII expression in epithelium in general and in liver where strong expression of TGF/? mRNA and proteins is found (Pelton et al., 1991; Millan et al., 1991) , suggests additional members of the TGFPRII are present in these tissues in compare to the TGFBRI (Wu et al., 1993; Q. Yu, personal communication.) .
The major expression of TGFPRII is restricted in the mesenchyme surrounding the epithelium of various embryonic organs. Numerous studies have shown that TGFP can mediate the synthesis of extracellular matrix protein (Ignotz and MassaguC, 1986) and protease inhibitors and repress the synthesis of protease thus preventing the degradation of the ECM. The net effect of TGF/3 action on mesenchymal cells is to promote an accumulation of extracellular matrix (Massague, 1990) . The predominant expression of TGFPRII in mesenchymal tissue where epithelial-mesenchymal interactions occur, suggests that one major role for TGFPRII during development is in the production of ECM and remodeling of embryonic organs during morphogenesis.. Analysis of FGF receptor expression during mouse embryogenesis reveals many overlapping expression domains with TGFBRII (Orr-Urtreger et al., 1991; Stark et al., 1991) . The synergistic action of FGF and TGFP in mesoderm induction (Jesse11 and Melton, 1992; Kimelman and Kirschner, 1987) and Raf-1 in mediating the induction of mesoderm by FGF (Macnicol et al., 1993) suggesting regulatory feedback between tyrosine kinase and serine/threonine kinase mediated responses. In summary, we demonstrate that TGFPRII is expressed in a spatially and temporally regulated manner during mouse embryogenesis. The expression pattern suggests that TGF/?RII may play an important role in establishment of embryonic organ systems via the epithelial-mesenchyme interaction and mediating key morphogenic events during tissue differentiation.
The spatial localization of TGFBRII in the developing CNS suggest an important role for serine/threonine kinase in nervous system patterning.
Materials and methods
Genomic clone isolation
Genomic DNA from the ES cell line, D3, derived from the SV129 mouse strain was partially digested with Sau3Al and then partially filled in with dGTP and dATP using the Klenow fragment of DNA Polymerase I (Stratagene).
The partially filled in genomic fragments were then ligated with premade Xho digested and d'lTP and dCTP partially filled in arms from lambda FIX (Stratagene) which were then packaged into phage using Gigapack II Gold packaging extract (Stratagene).
The phage mixture was then titered using P2392 strain of E. coli and lo6 plaque forming units were plated onto Falcon dishes. Nitrocellulose filters (Du Pont) were then lifted from the plates, autoclaved for 3 min and the resulting filters probed with a 200 bp 5' fragment of the human TGFj3 type IIR which had been random primed and labeled with [y-32P]dCTP (Amersham). A single phage clone was isolated and purified through two further rounds of plating with P2392 cells. The phage genomic insert was released with Sal1 (NEB) and subcloned into PBluescriptSK.
Extensive restriction enzyme mapping was undertaken, with Southern analysis of the digested DNA and the region of the 15 kb genomic clone containing exon 2 was narrowed to a 2 kB HincII/XmaI fragment. This was subcloned into PBSK and sequenced using T7 polymerase (USB). A smaller HincII/EcoRI fragment containing exon 2 of the mouse TGFBIIR was then subcloned into PBSK and used to make the probes used in the hybridization experiments.
Ribonuclease protection assay
Staged embryos were obtained from timed breedings of CD-l mice (Charles River) and the morning of vaginal plugs was considered as 0.5 days post-coitum (dpc) Total RNA from mouse embryos (9.5-17.5 dpc) and adult tissues was isolated using RNAzol (Cinna/Biotecx) according to the manufacturer's instructions. Antisense RNA probe of TGFPRII was synthesized in a reaction mixture containing 5OOpM of each of ATP, GTP, and UTP; 2.5pM of CTP; 125pglml of BSA; 5OpCi [32P]CTP (3000 Ci/mmol, New England Nuclear); lx transcription buffer, 0.5pg of template DNA, and 19 U of T3 polymerase in a total volume of 20~1 at 37'C for 30 min. The template was digested by RQ DNase 1 at 37'C for 15 min. For each assay, 2Opg of total RNA was incubated with 2 X lo5 decays/min of probe in 40 mM PIPES (pH 6.4), 400 mM NaCI, 1 mM EDTA, and 80% deionized formamide at 4245°C for 14-18 h. Samples were then digested with 5 U/ml RNase A and 150 U/ml RNase Tl for 30 min at 37°C. After phenol/chloroform extraction, samples were resolved on a 5% denaturing polyacrylamide gel (Song et al., 1992) .
In situ hybridization
In situ hybridization procedures used in this study were the same as previously described by Wang et al. (1992) . In brief, embryos were removed from the surrounding decidua and fixed in freshly prepared cold 4% paraformaldehyde in phosphate buffered saline for 16 h. Tissue was then slowly dehydrated and embedded into paraffin. Hybridization was carried out at 52'C for 16 h in 50% de-ionized formamide, 0.3 M NaCl, 20 mM TrisHCl (pH 7.4), 5 mM EDTA, 10 mM NaPO, (pH S), 10% dextran sulfate, 1 x Denhardt's, 50pg/ml total yeast RNA with 75 000 dpm/,,l 3sS-labeled RNA probe under siliconized coverslips. Antisense probes were generated using T3 RNA polymerase on a Bluescribe recombinant and [a-35S]UTP (>lOOO Ciimmol, New England Nuclear). Control sense probe was also generated using T7 RNA polymerase. Coverslips were then floated off in 5X SSC (1 x SSC is 0.15 M NaCl, 15 mM sodi,um citrate) 10 mM dithiothreitol (DTT), at 50°C followed by a stringent wash at 65°C in 50% formamide, 2~ SSC, 0.1 M DTT. Slides were then rinsed in washing buffer and treated with RNaseA (20pg/ml; Sigma) and washed at 37'C in 2X SSC and 0.1 X SSC for 15 min, respectively. Slides were then dehydrated rapidly and processed for standard autoradiography using NTB-2 Kodak emulsion and exposed for 7-9 days at 4°C. Analysis was carried out using both light and darkfield optics and photographed using a double exposure (dark field with red filter, bright field with light blue and green filters) on a Leitz Orthoplan microscope.
